Shopping Cart
- Remove All
Your shopping cart is currently empty
Anti-HLA-DR Antibody-PE (4D493)
🥰Excellent
Catalog No. TMAY-03604P
Anti-HLA-DR Antibody-PE (4D493) is a PE-conjugated Mouse antibody targeting HLA-DR. Anti-HLA-DR Antibody-PE (4D493) can be used in FCM.
Anti-HLA-DR Antibody-PE (4D493)
Anti-HLA-DR Antibody-PE (4D493)
🥰Excellent
Catalog No. TMAY-03604P
Anti-HLA-DR Antibody-PE (4D493) is a PE-conjugated Mouse antibody targeting HLA-DR. Anti-HLA-DR Antibody-PE (4D493) can be used in FCM.
Product information is being updated, if you want to purchase, please click the bulk custom button.
Bulk & Custom
Questions
View MoreContact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
| Description | Anti-HLA-DR Antibody-PE (4D493) is a PE-conjugated Mouse antibody targeting HLA-DR. Anti-HLA-DR Antibody-PE (4D493) can be used in FCM. |
| Ig Type | Monoclonal Mouse IgG1 |
| Clone | 4D493 |
| Reactivity | Human |
| Verified Activity | Flow cytometric analysis of Human HLA-DR expression on human whole blood lymphocytes. Cells were stained with PE-conjugated anti-Human HLA-DR. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. |
| Application | FCM |
| Recommended Dose | 0.5 μl/Test, 0.1 mg/ml |
| Antibody Type | Monoclonal |
| Host Species | Mouse |
| Construction | The monoclonal antibody was purified by affinity chromatography. Then it was conjugated with PE under optimum conditions, and the unreacted PE was removed. |
| Appearance | Liquid |
| Formulation | PBS solution containing 0.5% BSA and 0.09% sodium azide |
| Research Background | HLA-DR is a major histocompatibility complex (MHC) class II antigen presentation molecule, critical for the activation of lymphocytes and the orchestration of adaptive immune responses. HLA-DR is normally expressed on antigen-presenting cells including monocytes, macrophages, dendritic cells and B cells, but expression can be induced on epithelial cells and tumour cells in response to inflammatory conditions. MHC class II antigen presentation molecules are responsible for presentation of exogenous antigens to CD4+helper T cells. HLA-DR expression in tumours has been positively associated with enhanced lymphocytic infiltration. HLA-DR has been used as a surrogate marker of immune competence in various clinical studies, and its loss in circulation has been linked with susceptibility to post-surgical infection and sepsis. |
| Conjucates | PE |
| Others Formats | FITC |
| Antibody Types Available | 2 |
| Immunogen | 0 |
| Antigen Species | Human |
Stability & Storage
| Stability & Storage | Store at 2°C-8°C for 12 months, do not freeze. Keep away from direct sunlight. Sodium azide is toxic to cells and should be disposed of properly. Flush with large volumes of water during disposal. |
| Transport | Shipping with blue ice. |
Sci Citations
Calculator
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . 
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Anti-HLA-DR Antibody-PE (4D493) | purchase Anti-HLA-DR Antibody-PE (4D493) | Anti-HLA-DR Antibody-PE (4D493) cost | order Anti-HLA-DR Antibody-PE (4D493)
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.